http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103936628-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10c3f12979e7751f6e54ae5594988766
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-06
filingDate 2013-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc128b4453568bce7d7381bd9a5c71a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f3d8cee2acaa41321a8d61f3fdf7853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56a869e0617700204cec370543e9feee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c11b8ba626e745ce7a3eb17aef3037b4
publicationDate 2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103936628-A
titleOfInvention Intermediate V of anti-hepatitis C drug Boceprevir and its preparation method and application
abstract The invention relates to the technical field of preparation methods for anti-hepatitis C drug Boceprevir. The structural formula of compound V (E) provided by the present invention is as follows. The preparation of this type of compound has the advantages of simple operation and high yield. The compound can be used for the synthesis of the anti-hepatitis C drug Boceprevir, which provides a new idea and method for the synthesis of the anti-hepatitis C drug Boceprevir. Moreover, the ultraviolet chromogenic group in the molecule of this type of compound is more convenient to detect than the original synthesis method. In addition, the introduction of the benzyl group on the hydroxyl group avoids the side reaction caused by the nucleophilicity of the hydroxyl group in the condensation step, which is different from the existing synthetic method. Compared with certain advantages.
priorityDate 2013-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010138889-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102206247-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411460737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467299140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19017814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465961099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467665103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421130655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467214425

Total number of triples: 26.